Lithium Carbonate
Li₂CO₃ | CAS: 554-13-2 | HS: 28369100
Product Description
Lithium Carbonate sits at the intersection of two of the fastest-growing sectors in global industry: battery energy storage and pharmaceuticals. Battery-grade Li₂CO₃ (99.5%+ purity, ultra-low impurity profile) is a primary precursor in the synthesis of cathode active materials for lithium-ion batteries — the technology powering electric vehicles, grid storage, and consumer electronics. Pharmaceutical-grade lithium carbonate is a WHO essential medicine used for decades in treating bipolar disorder. MITCHEM supplies both grades with grade-specific documentation — battery grade with ICP-MS impurity certificates, pharmaceutical grade with full pharmacopeial CoA.
Applications by Industry
Precursor for synthesising LCO, NMC, and LFP cathode active materials; battery-grade purity (99.5%+ with <10 ppm key impurities) is essential for consistent electrochemical performance.
Active pharmaceutical ingredient in lithium carbonate tablets and capsules for the treatment of bipolar disorder and manic episodes; a WHO essential medicine in continuous use since the 1970s.
Flux and stabiliser in specialty glass, glass-ceramics, and ceramic glazes, reducing melting temperature and improving thermal expansion control.
Feedstock for producing lithium hydroxide, lithium chloride, lithium nitrate, and other downstream lithium salts.
Added to molten cryolite bath in aluminium electrolysis cells to increase bath conductivity and reduce energy consumption per tonne of aluminium produced.